US FDA Poses Next-Level GMP Challenges For Aurobindo's Polepally Site

 
• By Bowman Cox

Agency conducts follow-up inspection as Aurobindo's Polepally, India, manufacturing facility looks to move on from crippling OAI designation.

broken tablet
aurobindo may be putting it together again at polepally • Source: Shutterstock

More from Manufacturing

More from Compliance